September 2024

Stability milestone supports submission of FDA New Drug Application by NRx for the use of intravenous ketamine to treat Suicidal Depression Ketamine is currently used off-label for this indication. However, FDA approval is typically required for patients to obtain insurance reimbursement NRX-100 is

MONTREAL, Sept. 30, 2024 /CNW/ – METRO INC. declares a quarterly dividend of $0.3350 per common share, which is the same amount as the quarterly dividend declared for the previous quarter. This dividend is payable on November 12, 2024, to shareholders of record as of October 24, 2024. À prop

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: